NCT07347782Not yet recruiting
AI-Based Speech Intelligibility Assessment: Efficacy & Reliability
Clinical Study on the Efficacy and Reliability of Speech Intelligibility Assessment for Post-stroke Patients Using an AI Solution
Source: ClinicalTrials.gov · Last updated 16 Jan 2026
Brief summary (registry, in English)
compare the auditory-perceptual assessment conducted by speech-language pathologists using the U-TAP with the assessment performed via the AI solution (Blings) program in patients with speech disorders, and to evaluate the efficacy and reliability of these two methods for speech intelligibility assessment.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 40 (estimated)
- First submitted
- 22 Dec 2025
- Start date
- Feb 2026
- Primary completion date
- 31 Dec 2026
- Lead sponsor
- Pusan National University Yangsan Hospital
- Diseases
- Stroke
- NCT number
- NCT07347782
What you commit to
- Study type: Observational
- Planned participants: 40
- From Feb 2026 to the primary completion date, 31 Dec 2026
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Subjects with a score of less than 16 points on the Korean Mini-Mental State Examination (K-MMSE).
- Subjects with visual, perceptual, or auditory impairments that prevent them from following the examiner's instructions.
- Subjects judged by the researcher as unsuitable for participation in this clinical study due to other reasons.
Who the study is looking for
- Adults aged 18 years or older.
- Patients with neurologic disorders, including amyotrophic lateral sclerosis, poliomyelitis, cerebellar disorders, cerebellar lesions, and stroke.
- Patients presenting with concomitant speech disorders, such as dysarthria, motor speech disorders, and voice disorders.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.